首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1705708

全球儿科灌注市场按产品类型、应用、最终用户和地区划分

Global Pediatric Perfusion Market, By Product Type, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2025 年全球儿科灌注市场规模估计为 5.753 亿美元，预计到 2032 年将达到 8.425 亿美元，2025 年至 2032 年的复合年增长率为 5.6%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	5.753亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	5.60%	2032年价值预测	8.425亿美元

数字。 2025年全球市场占有率（按地区）

儿科灌注是指在开胸心臟外科手术期间透过接受心肺体外迴圈(CPB) 的儿童的循环系统泵送血液。 CPB 涉及透过心肺机转移患者的血液循环，以维持血液循环和肺部气体交换，同时心臟停止跳动以进行手术修復的某些部分。儿科灌注需要专门的设备、技术和技能来适应成人和儿科患者之间的解剖和生理差异。在过去的几十年里，灌注技术的进步、电路设计的改进以及儿科手术技术的创新显着提高了手术的成功率。然而，先天性心臟疾病仍然是全球婴儿死亡的主要原因之一。

市场动态：

世界卫生组织 (WHO) 估计，先天性心臟疾病(CHD) 影响近 1% 的新生儿。诊断技术的进步使得能够早期发现先天性心臟病，再加上儿科心臟外科手术的进步，提高了存活率和治疗效果。因此，受益于小儿心血管手术和小儿灌注服务的儿童数量正在增加。

儿科灌注使用心肺机在心血管手术期间为儿童提供心肺支持。随着越来越多的新生儿和婴儿被诊断出患有先天性心臟病并接受矫正和姑息手术，对专门灌注设备的需求正在增加。外科手术的进步使得人们能够更早进行复杂的心血管手术，从而提高先天性心臟病儿童的寿命和生活品质。

然而，儿科灌注市场也面临挑战。小儿心血管手术的高昂费用会给医疗保健系统和家庭带来沉重的经济负担，尤其是在缺乏全面医疗保险覆盖的地区。此外，儿科灌注需要特殊的专业知识，并且缺乏训练有素的儿科灌注师。另一个挑战是人们越来越关注非体外循环手术，这可能会限制灌注装置的市场。由于这些手术无需停止心臟即可进行，因此不需要心肺机，从而有可能减少对灌注服务的需求。

儘管有这些挑战，儿科灌注市场仍存在着巨大的机会，特别是在微型灌注设备的创新和开发方面。这些设备更适合新生儿和婴儿的生理需要，提供更精确的控制和更少的併发症。这是儿科心臟护理领域的重大进步，为市场参与者提供了极具吸引力的机会。新兴市场的医疗保健基础设施正在不断扩大，儿科心臟护理服务也正在改善，因此也具有成长潜力。这些地区对医疗保健服务的需求激增，这可能会推动市场扩张。

摘要：随着医学的不断进步，如果能够从策略上解决成本、培训和技术挑战，全球儿科灌注市场将有望实现成长。製造商和医疗保健提供者可以透过投资专为儿科护理设计的专业、经济高效且技术先进的灌注系统来利用这些机会。

本研究的主要特点

本报告对全球儿科灌注市场进行了详细分析，并给出了预测期（2025-2032 年，以 2024 年为基准年）的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、绩效和策略等参数，介绍了全球儿科灌注市场的主要企业概况。
本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球儿科灌注市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
可以透过用于分析全球儿科灌注市场的各种策略矩阵来促进相关人员的决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 575.3 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	5.60%	2032 Value Projection:	USD 842.5 Mn

Pediatric perfusion is the delivery of blood through the circulatory system in children undergoing cardiopulmonary bypass (CPB) during open heart surgery. CPB involves diverting the patient's blood circulation through a heart-lung machine to maintain circulation and lung gas exchange while the heart is stopped during specific parts of the surgical repair. Pediatric perfusion requires specialized equipment, techniques, and skills to handle the anatomical and physiological differences between adult and pediatric patients. Over the past few decades, procedural success rates have significantly improved due to advancements in perfusion technologies, circuit design modifications, and innovations in surgical techniques tailored for children. However, congenital heart defects continue to be one of the major causes of infant mortality worldwide.

Market Dynamics:

The global pediatric perfusion market is experiencing growth primarily due to the increasing incidence of congenital heart diseases (CHD), a condition affecting nearly 1% of live births according to World Helath Organization (WHO) estimates. Improved diagnostic techniques have led to the early identification of CHD, which, coupled with advancements in pediatric cardiac surgical procedures, has improved survival rates and outcomes. Consequently, this has elevated the number of children who can benefit from pediatric cardiac surgeries and, by extension, pediatric perfusion services.

Pediatric perfusion involves the use of a heart-lung machine to support the child's cardiopulmonary functions during cardiac surgery. As more newborns and infants are diagnosed with CHD and undergo corrective or palliative surgeries, the demand for specialized perfusion equipment has grown. The surgical advancements have allowed for complex cardiac interventions to be performed at earlier stages of life, extending the longevity and quality of life of pediatric CHD patients.

However, the pediatric perfusion market does face challenges. The high cost of pediatric cardiac surgeries can be a significant financial burden for healthcare systems and families, particularly in regions without comprehensive health insurance coverage. Moreover, pediatric perfusion requires specific expertise, and there is a recognized gap in the availability of trained pediatric perfusionists. Another challenge is the increasing focus on off-pump surgical procedures, which can limit the market for perfusion equipment. These surgeries, performed without stopping the heart, may not require a heart-lung machine, thereby decreasing the demand for perfusion services.

Despite these challenges, there are substantial opportunities in the pediatric perfusion market, particularly in the innovation and development of miniaturized perfusion equipment. These devices are better suited for the physiological needs of neonates and infants, offering more precise control and reduced complications. This represents a significant advancement in pediatric cardiac care, offering an attractive opportunity for players in the market. There is also potential for growth in emerging markets, where healthcare infrastructure is expanding, and access to pediatric cardiac care is improving. The burgeoning demand for healthcare services in these regions can stimulate market expansion.

In summary, as medical advancements continue, the global pediatric perfusion market is well-positioned for growth, provided that challenges around costs, training, and technology are strategically addressed. Manufacturers and healthcare providers can capitalize on these opportunities by investing in specialized, cost-effective, and technologically advanced perfusion systems designed for pediatric care.

Key Features of the Study:

This report provides an in-depth analysis of the global pediatric perfusion market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032, considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pediatric perfusion market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, GE Healthcare, LivaNova, PLC., Getinge, Braile Biomedica, XENIOS AG, BL Lifesciences, Terumo Corporation, 3M, Koninklijke Philips N.V., EUROSETS, Merck KGaA, Stryker, Cardinal Health, Nonin, and Sorin Group USA, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global pediatric perfusion market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pediatric perfusion market

Detailed Segmentation:

By Product Type:
- Pediatric Cannulas
- Centrifugal Blood Pumps
- Pediatric Arterial Lines
- Membrane Oxygenators
- Extracorporeal Circuits
- Others
By Application
- Cardiovascular Surgery
- Respiratory Applications
- Extracorporeal Membrane Oxygenation
- Cardiopulmonary Bypass
- Organ Perfusion and Preservation
- Organ Transplantation
- Others
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Medtronic
- GE Healthcare
- LivaNova, PLC.
- Getinge
- Braile Biomedica
- XENIOS AG
- BL Lifesciences
- Terumo Corporation
- 3M
- Koninklijke Philips N.V.
- EUROSETS
- Merck KGaA
- Stryker
- Cardinal Health
- Nonin
- Sorin Group USA, Inc.\

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Pediatric Perfusion Market, By Product Type
- Pediatric Perfusion Market, By Application
- Pediatric Perfusion Market, By End User
- Pediatric Perfusion Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- The increasing incidence of cardiovascular diseases (CVDs) in the pediatric population
- Increasing government initiatives and funding
- The emergence of new technologies in pediatric perfusion
- Technological advancements
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Pediatric Perfusion Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pediatric Perfusion Market, By Product Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Pediatric Cannulas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Centrifugal Blood Pumps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Pediatric Arterial Lines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Membrane Oxygenators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Extracorporeal Circuits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

6. Global Pediatric Perfusion Market, By Application, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Cardiovascular Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Respiratory Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Extracorporeal Membrane Oxygenation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Cardiopulmonary Bypass
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Organ Perfusion and Preservation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Organ Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Global Pediatric Perfusion Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

8. Global Pediatric Perfusion Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Medtronic
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GE Healthcare
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
LivaNova, PLC.
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Getinge
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Braile Biomedica
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
XENIOS AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
BL Lifesciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
3M
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
EUROSETS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Stryker
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
Cardinal Health
Nonin
Sorin Group USA, Inc.
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球儿科灌注市场按产品类型、应用、最终用户和地区划分